Beyond Air, Inc. (XAIR) |
|
7.42 0.73 (10.91%)
|
07-02 15:39 |
|
Open: |
6.67 |
Pre. Close: |
6.69 |
|
High:
|
7.45 |
Low:
|
6.51 |
|
Volume:
|
751,436 |
Market Cap:
|
221(M) |
|
|
|
|
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.46 - 7.49 |
7.49 - 7.52 |
|
Low:
|
6.44 - 6.47 |
6.47 - 6.5 |
|
Close:
|
7.37 - 7.42 |
7.42 - 7.48 |
|
Technical analysis |
as of: 2022-07-01 4:26:19 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 8.7  One year: 10.16 |
| Support: |
Support1: 5.87 Support2: 4.9 |
| Resistance: |
Resistance1: 7.44 Resistance2: 8.7 |
| Pivot: |
5.96 |
| Moving Average: |
MA(5): 6.48 MA(20): 5.86
MA(100): 6.43  MA(250): 8.48 |
| MACD: |
MACD(12,26): 0.2 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 74.6 %D(3): 58.5 |
| RSI: |
RSI(14): 65.6 |
| 52-week: |
High: 16.4 Low: 4.78 |
| Average Vol(K): |
3-Month: 413 (K) 10-Days: 994 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ XAIR ] has closed above the upper band by 4.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 73.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 30 Jun 2022
Two 18 x Air Jordan 2 Low DV7129-222 Release Date - Sneaker Bar Detroit
Wed, 29 Jun 2022
Hot Stocks: CCL, UPST fall on bearish analyst comments; MKC slips on earnings - Seeking Alpha
Wed, 29 Jun 2022
Beyond Air (XAIR) Stock Gains Almost 20% on FDA Approval - InvestorPlace
Wed, 29 Jun 2022
Pre-market Movers: TWOU, XAIR, AGRX, NRGV, ICVX… - Nasdaq
Tue, 28 Jun 2022
Stock Futures Level After Consumer Confidence Index Underwhelms - Barron's
Tue, 28 Jun 2022
After-Hours Earnings Report for June 28, 2022 : PRGS, AVAV, XAIR, AEMD - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
27 (M) |
|
% Held by Insiders
|
2.563e+007 (%) |
|
% Held by Institutions
|
16 (%) |
|
Shares Short
|
974 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-2.504e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-17 |
|
Return on Assets (ttm)
|
434.7 |
|
Return on Equity (ttm)
|
-25.5 |
|
Qtrly Rev. Growth
|
145190 |
|
Gross Profit (p.s.)
|
0.03 |
|
Sales Per Share
|
0.01 |
|
EBITDA (p.s.)
|
-0.88 |
|
Qtrly Earnings Growth
|
-1.3 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-21 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
671.9 |
|
Price to Cash Flow
|
-2.52 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
1.09e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2017-01-09 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
